Back to Search
Start Over
The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis
- Source :
- Cancers, Volume 13, Issue 7, Cancers, 2021, 13 (7), ⟨10.3390/cancers13071721⟩, Cancers, MDPI, 2021, 13 (7), ⟨10.3390/cancers13071721⟩, Cancers, Vol 13, Iss 1721, p 1721 (2021)
- Publication Year :
- 2021
- Publisher :
- Multidisciplinary Digital Publishing Institute, 2021.
-
Abstract
- Non-alcoholic fatty liver disease (NAFLD) and progression to non-alcoholic steatohepatitis (NASH) result as a consequence of diverse conditions, mainly unbalanced diets. Particularly, high-fat and cholesterol content, as well as carbohydrates, such as those commonly ingested in Western countries, frequently drive adverse metabolic alterations in the liver and promote NAFLD development. Lipid liver overload is also one of the main risk factors for initiation and progression of hepatocellular carcinoma (HCC), but detailed knowledge on the relevance of high nutritional cholesterol remains elusive. We were aimed to characterize HCC development in mice fed with a Western diet (high in lipids and cholesterol) and to identify molecular alterations that define a subtype of liver cancer induced by lipid overload. Mice under western or high cholesterol diets more frequently developed tumors with a more aggressive phenotype than animals fed with a chow diet. Associated changes involved macrophage infiltration, angiogenesis, and stemness features. RNA-seq revealed a specific gene expression signature (Slc41a<br />Fabp5<br />Igdcc4 and Mthfd1l) resembling the adverse phenotypic features and poor clinical outcomes seen in patients with HCC. In conclusion<br />consumption of lipid enriched diets<br />particularly cholesterol<br />could accelerate HCC development with an aggressive phenotype and poor prognosis
- Subjects :
- 0301 basic medicine
Cancer Research
Physiology
[SDV.CAN]Life Sciences [q-bio]/Cancer
Disease
lcsh:RC254-282
High cholesterol
Article
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
[SDV.CAN] Life Sciences [q-bio]/Cancer
NAFLD
medicine
HCC
Western diet
Cholesterol
business.industry
Fatty liver
NASH
cholesterol
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
medicine.disease
Phenotype
digestive system diseases
3. Good health
030104 developmental biology
Oncology
chemistry
030220 oncology & carcinogenesis
Hepatocellular carcinoma
Steatohepatitis
Liver cancer
business
Subjects
Details
- Language :
- English
- ISSN :
- 20726694
- Database :
- OpenAIRE
- Journal :
- Cancers
- Accession number :
- edsair.doi.dedup.....4731157645acce054cdcc977ed0729f8
- Full Text :
- https://doi.org/10.3390/cancers13071721